← Evidence map

ReviewDrugs2018

BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers.

Jaquelyn N Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

82 papers cite itlatest 60 shown

2018
…
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29488071